Teladoc Health Statistics
Total Valuation
Teladoc Health has a market cap or net worth of $1.41 billion. The enterprise value is $1.69 billion.
Important Dates
The next estimated earnings date is Thursday, April 24, 2025, after market close.
| Earnings Date | Apr 24, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Teladoc Health has 173.67 million shares outstanding. The number of shares has increased by 3.64% in one year.
| Current Share Class | 173.67M |
| Shares Outstanding | 173.67M |
| Shares Change (YoY) | +3.64% |
| Shares Change (QoQ) | +0.74% |
| Owned by Insiders (%) | 0.96% |
| Owned by Institutions (%) | 66.72% |
| Float | 159.59M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.54 |
| Forward PS | 0.55 |
| PB Ratio | 0.94 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 4.97 |
| P/OCF Ratio | 4.78 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 53.31, with an EV/FCF ratio of 5.98.
| EV / Earnings | n/a |
| EV / Sales | 0.66 |
| EV / EBITDA | 53.31 |
| EV / EBIT | n/a |
| EV / FCF | 5.98 |
Financial Position
The company has a current ratio of 1.77, with a Debt / Equity ratio of 1.06.
| Current Ratio | 1.77 |
| Quick Ratio | 1.62 |
| Debt / Equity | 1.06 |
| Debt / EBITDA | 35.23 |
| Debt / FCF | 5.60 |
| Interest Coverage | -8.77 |
Financial Efficiency
Return on equity (ROE) is -52.46% and return on invested capital (ROIC) is -3.73%.
| Return on Equity (ROE) | -52.46% |
| Return on Assets (ROA) | -3.30% |
| Return on Invested Capital (ROIC) | -3.73% |
| Return on Capital Employed (ROCE) | -8.11% |
| Revenue Per Employee | $467,195 |
| Profits Per Employee | -$182,045 |
| Employee Count | 5,500 |
| Asset Turnover | 0.65 |
| Inventory Turnover | 22.21 |
Taxes
In the past 12 months, Teladoc Health has paid $7.59 million in taxes.
| Income Tax | 7.59M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -47.02% in the last 52 weeks. The beta is 1.27, so Teladoc Health's price volatility has been higher than the market average.
| Beta (5Y) | 1.27 |
| 52-Week Price Change | -47.02% |
| 50-Day Moving Average | 10.24 |
| 200-Day Moving Average | 9.39 |
| Relative Strength Index (RSI) | 35.62 |
| Average Volume (20 Days) | 6,290,680 |
Short Selling Information
The latest short interest is 26.82 million, so 15.44% of the outstanding shares have been sold short.
| Short Interest | 26.82M |
| Short Previous Month | 22.02M |
| Short % of Shares Out | 15.44% |
| Short % of Float | 16.80% |
| Short Ratio (days to cover) | 2.34 |
Income Statement
In the last 12 months, Teladoc Health had revenue of $2.57 billion and -$1.00 billion in losses. Loss per share was -$5.87.
| Revenue | 2.57B |
| Gross Profit | 1.82B |
| Operating Income | -208.79M |
| Pretax Income | -997.92M |
| Net Income | -1.00B |
| EBITDA | 31.72M |
| EBIT | -208.79M |
| Loss Per Share | -$5.87 |
Full Income StatementBalance Sheet
The company has $1.30 billion in cash and $1.58 billion in debt, giving a net cash position of -$286.29 million or -$1.65 per share.
| Cash & Cash Equivalents | 1.30B |
| Total Debt | 1.58B |
| Net Cash | -286.29M |
| Net Cash Per Share | -$1.65 |
| Equity (Book Value) | 1.49B |
| Book Value Per Share | 8.60 |
| Working Capital | 722.37M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $293.68 million and capital expenditures -$10.79 million, giving a free cash flow of $282.89 million.
| Operating Cash Flow | 293.68M |
| Capital Expenditures | -10.79M |
| Free Cash Flow | 282.89M |
| FCF Per Share | $1.63 |
Full Cash Flow StatementMargins
Gross margin is 70.76%, with operating and profit margins of -8.13% and -38.97%.
| Gross Margin | 70.76% |
| Operating Margin | -8.13% |
| Pretax Margin | -38.67% |
| Profit Margin | -38.97% |
| EBITDA Margin | 1.23% |
| EBIT Margin | -8.13% |
| FCF Margin | 11.01% |
Dividends & Yields
Teladoc Health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -3.64% |
| Shareholder Yield | -3.64% |
| Earnings Yield | -71.26% |
| FCF Yield | 20.13% |
Dividend DetailsAnalyst Forecast
The average price target for Teladoc Health is $11.26, which is 39.18% higher than the current price. The consensus rating is "Buy".
| Price Target | $11.26 |
| Price Target Difference | 39.18% |
| Analyst Consensus | Buy |
| Analyst Count | 18 |
| Revenue Growth Forecast (5Y) | 3.75% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Teladoc Health has an Altman Z-Score of -5.08 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -5.08 |
| Piotroski F-Score | 4 |